Zdrowie i gospodarka · 23/04/2020

FDA Extends Comment Period for Gene Therapy Guidance

The US Food and Drug Administration (FDA) is extending the comment period for its draft guidance on gene therapy products under the Orphan Drug Regulations, allowing interested parties more time to submit comments.